Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolismStephen Jun Fei Chong, Shazib Pervaiz, Kartini Iskandar et al.|Nucleic Acids Research|2020Cited by 63
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemiaCharles Herbaux, Matthew S. Davids, Christoph Kornauth et al.|Blood|2021Cited by 37
Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life populationZoé Van de Wyngaert, Eileen M. Boyle, Sarah Barbieux et al.|British Journal of Haematology|2019Cited by 29
THE COMBINATION OF VENETOCLAX AND IBRUTINIB IS EFFECTIVE IN RELAPSED/REFRACTORY T‐PROLYMPHOCYTIC LEUKEMIA AND INFLUENCES BCL‐2‐FAMILY MEMBER DEPENDENCIESChristoph Kornauth, Philipp B. Staber, Charles Herbaux et al.|Hematological Oncology|2019Cited by 10
Efficacy and Safety of Daratumumab in a Frail Real-Life Relapsed or Refractory Systemic Light-Chain Amyloidosis Population (AL): Report on 15 Cases from the North of FranceZoé Van de Wyngaert, Eileen M. Boyle, Benjamin Carpentier et al.|Blood|2018Cited by 6